Breast Cancer Treatment
- PMID: 34383430
Breast Cancer Treatment
Abstract
Breast cancer is the leading cause of death from cancer in women worldwide, and the second most common cause of death from cancer in women in the United States. Risk assessment tools can identify the risk of breast cancer, and patients at high risk may be candidates for risk-reducing medications. The choice of medication varies with menopausal status. Breast cancer treatment depends on the stage. Stage 0 is ductal carcinoma in situ, which is noninvasive but progresses to invasive cancer in up to 40% of patients. Ductal carcinoma in situ is treated with lumpectomy and radiation or with mastectomy. If ductal carcinoma in situ is estrogen receptor-positive, patients may also receive endocrine therapy. Early invasive stages (I, IIa, IIb) and locally advanced stages (IIIa, IIIb, IIIc) are nonmetastatic and have three treatment phases. The preoperative phase uses systemic endocrine or immunotherapies when tumors express estrogen, progesterone, or ERBB2 receptors. Preoperative chemotherapy may also be used and is the only option when tumors have none of those three receptors. There are two options for the surgical phase with similar survival rates; a lumpectomy with radiation if the tumor can be excised completely with good cosmetic results, or a mastectomy. Sentinel lymph node biopsy is also performed when there is suspected nodal disease. The postoperative phase includes radiation, endocrine therapy, immunotherapy, and chemotherapy. Postmenopausal women should also be offered postoperative bisphosphonates. Stage IV (metastatic) breast cancer is treatable but not curable. Treatment goals include improving the length and quality of life.
Similar articles
-
Treatment of breast cancer.Am Fam Physician. 2010 Jun 1;81(11):1339-46. Am Fam Physician. 2010. PMID: 20521754 Review.
-
Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.Prescrire Int. 2013 Dec;22(144):298-303. Prescrire Int. 2013. PMID: 24600734 Review.
-
Neoadjuvant Systemic Therapy Use for Younger Patients with Breast Cancer Treated in Different Types of Cancer Centers Across the United States.J Am Coll Surg. 2016 Nov;223(5):717-728.e4. doi: 10.1016/j.jamcollsurg.2016.08.541. J Am Coll Surg. 2016. PMID: 27788894 Free PMC article.
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.Semin Oncol. 2001 Aug;28(4):400-18. doi: 10.1016/s0093-7754(01)90133-2. Semin Oncol. 2001. PMID: 11498833 Clinical Trial.
Cited by
-
Accuracy and Utility of Preoperative Ultrasound-Guided Axillary Lymph Node Biopsy for Invasive Breast Cancer: A Systematic Review and Meta-Analysis.Comput Intell Neurosci. 2022 Sep 27;2022:3307627. doi: 10.1155/2022/3307627. eCollection 2022. Comput Intell Neurosci. 2022. PMID: 36203726 Free PMC article. Review.
-
Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis.Cancers (Basel). 2023 Dec 29;16(1):168. doi: 10.3390/cancers16010168. Cancers (Basel). 2023. PMID: 38201595 Free PMC article.
-
Types of Breast Cancer Surgery and Breast Reconstruction.Cancers (Basel). 2024 Sep 20;16(18):3212. doi: 10.3390/cancers16183212. Cancers (Basel). 2024. PMID: 39335183 Free PMC article. Review.
-
Enhanced anticancer synergy of LOM612 in combination with selinexor: FOXO1 nuclear translocation-mediated inhibition of Wnt/β-catenin signaling pathway in breast cancer.Cancer Chemother Pharmacol. 2024 Mar;93(3):191-202. doi: 10.1007/s00280-023-04618-4. Epub 2023 Dec 5. Cancer Chemother Pharmacol. 2024. PMID: 38051377
-
CMTM7 recognizes an immune-hot tumor microenvironment and predicts therapeutic response of immunotherapy in breast cancer well.Front Genet. 2022 Dec 7;13:1051269. doi: 10.3389/fgene.2022.1051269. eCollection 2022. Front Genet. 2022. PMID: 36568362 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous